Fig. 6From: Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trialsOverall analysis of denosumab versus ZA. Forest plots of incidence of acute phase reaction (A), hypocalcaemia (B), ONJ (C), and new primary malignancy (D)Back to article page